NHS Approves New Antibody Treatment for Aggressive Cancer

The NHS has approved a new antibody treatment, also known as Ziihera, for aggressive cancer. This treatment targets the HER2 protein, activating the immune system to eliminate cancer cells and potentially tripling life expectancy.

20 Apr, 23:01 — 20 Apr, 23:01

Post Share

Sources

Showing 1 of 1 sources

The IndependentMostly Factual61d ago

NHS approves new treatment for aggressive cancer that could triple life expectancy

Also known as Ziihera, the antibody treatment targets a protein called HER2, which stimulates tumour growth. It works by activating the immune system to eliminate cancer cells and reduces HER2 levels

By Ella Pickover

Read full article →

PERSPECTA

PERSPECTA

NHS Approves New Antibody Treatment for Aggressive Cancer

Sources

NHS approves new treatment for aggressive cancer that could triple life expectancy

Related Stories

Scientists Discover Largest Ancient Scorpion, Size of a Dog

'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video

New Study Suggests Earth May Avoid Being Swallowed by the Sun

Astronomers Observe Extremely Distant Radio Galaxy, Light Traveled 12 Billion Years

PERSPECTA